FDA Approves First Gene Therapy Clinical Trial For Rare Disease – Hartford Courant
Hartford Courant |
FDA Approves First Gene Therapy Clinical Trial For Rare Disease
Hartford Courant The ultimate goal for the gene therapy, according to David Weinstein, a key researcher and pediatric endocrinologist, is to prevent low blood sugars, eliminate the dependence on cornstarch and allow patients to have normal lives. The gene therapy is … |
